Greg Lucier joins Invuity’s Board of Directors

Former CEO of Life Technologies Corporation joins board of advanced photonics medical device company


SAN FRANCISCO, Calif., October 28, 2014 – Invuity, Inc., a medical device company that is addressing the inherent challenges of minimally invasive surgery and transforming patient outcomes through its proprietary advanced photonics devices, announced today that life sciences industry veteran Gregory T. Lucier has been named to its Board of Directors.

“Invuity is building an innovative and important new category that has the potential to truly transform surgery,” said Lucier. “I am looking forward to working with the team to continue to scale the company.”

Lucier is the former chairman and chief executive officer of Life Technologies Corporation, a global life sciences company that was acquired by Thermo Fisher Scientific in 2013. At Life Technologies, Lucier led the transformation of the company from a biotechnology tools company with sales of $600 million into one of the largest life sciences companies in the world with sales of close to $4 billion, ultimately being sold to Thermo Fisher for more than $16 billion.  Lucier led Life Technologies’ expansion into broad new categories as well as its growth into a leading global entity.

“Greg Lucier is a luminary in the life sciences industry,” said Invuity Chief Executive Officer Philip Sawyer. “His dynamic leadership in creating substantial growth and value in innovative technology categories make him an ideal board member. We look forward to having Greg as a partner as we significantly scale our business.”

Prior to Life Technologies, Lucier held several senior management positions with General Electric Company (GE) from 1995 to 2003, and was most recently chief executive officer and president of Medical Systems Information Technologies for GE Healthcare.

Lucier received a Bachelor of Science degree with high distinction in Industrial Engineering from Pennsylvania State University and a Master of Business Administration degree from The Harvard Business School.

About Invuity®

Invuity, Inc., headquartered in San Francisco, develops and markets a series of Intelligent Photonics Technology™ products that make possible new minimally invasive surgical approaches and techniques that result in better, faster and safer surgical outcomes for patients. Clinical applications include breast and thyroid oncology, plastics, spine, orthopedic, and general surgery among others. For more information, visit www.invuity.com.